Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Demannose. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | MPI | P34949 | 1/20 | 0.44 |
| ▸ | PDE4A | P27815 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Demannose SCHEMBL30973585 | 1.00 | LMNA (0.48) | LMNAL3MBTL1TDP1MPIPDE4A | |
| Demannose SCHEMBL3397670 | 1.00 | LMNA (0.48) | LMNAL3MBTL1TDP1MPIPDE4A | |
| Demannose SCHEMBL31755099 | 1.00 | LMNA (0.48) | LMNAL3MBTL1TDP1MPIPDE4A | |
| Demannose SCHEMBL23721809 | 1.00 | LMNA (0.48) | LMNAL3MBTL1TDP1MPIPDE4A | |
| Demannose SCHEMBL285569 | 1.00 | LMNA (0.48) | LMNAL3MBTL1TDP1MPIPDE4A | |
| Demannose SCHEMBL25380809 | 1.00 | LMNA (0.48) | LMNAL3MBTL1TDP1MPIPDE4A | |
| Demannose SCHEMBL6533561 | 1.00 | LMNA (0.48) | LMNAL3MBTL1TDP1MPIPDE4A | |
| Demannose SCHEMBL25381696 | 1.00 | LMNA (0.48) | LMNAL3MBTL1TDP1MPIPDE4A | |
| Galactose SCHEMBL361095 | 1.00 | LMNA (0.48) | LMNAL3MBTL1TDP1MPIPDE4A | |
| Demannose SCHEMBL30572907 | 1.00 | LMNA (0.48) | LMNAL3MBTL1TDP1MPIPDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 518 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4448733-A1 | SIALYLTRANSFERASES FOR THE PRODUCTION OF SIALYLATED OLIGOSACCHARIDES | Inbiose N.V. (BE) | 2024-10-23 | — | — | EP | claimed |
| EP-4323512-A1 | CELLULAR PRODUCTION OF BIOPRODUCTS | Inbiose N.V. (BE) | 2024-02-21 | — | — | EP | claimed |
| CN-115254158-B | Nanocluster metal phosphide-phosphorus-carbon catalyst and preparation and application thereof | 中国科学院兰州化学物理研究所 | 2023-12-22 | — | — | CN | claimed |
| EP-4263816-A1 | VARIANT SUCROSE PERMEASE POLYPEPTIDES | Inbiose N.V. (BE) | 2023-10-25 | — | — | EP | claimed |
| WO-2023111141-A1 | SIALYLTRANSFERASES FOR THE PRODUCTION OF SIALYLATED OLIGOSACCHARIDES | INBIOSE N.V. (BE) | 2023-06-22 | — | — | WO | claimed |
| EP-4192969-A1 | PRODUCTION OF AN OLIGOSACCHARIDE MIXTURE BY A CELL | Inbiose N.V. (BE) | 2023-06-14 | — | — | EP | claimed |
| EP-4192944-A1 | PRODUCTION OF OLIGOSACCHARIDE MIXTURES BY A CELL | Inbiose N.V. (BE) | 2023-06-14 | — | — | EP | claimed |
| EP-4192973-A2 | PRODUCTION OF GALACTOSYLATED DI- AND OLIGOSACCHARIDES | Inbiose N.V. (BE) | 2023-06-14 | — | — | EP | claimed |
| EP-4192968-A1 | PRODUCTION OF FUCOSYLATED LACTOSE STRUCTURES BY A CELL | Inbiose N.V. (BE) | 2023-06-14 | — | — | EP | claimed |
| EP-4192967-A1 | PRODUCTION OF A MIXTURE OF NEUTRAL FUCOSYLATED OLIGOSACCHARIDES BY A CELL | Inbiose N.V. (BE) | 2023-06-14 | — | — | EP | claimed |
| WO-2002096409-A1 | USE OF ACETYL L-CARNITINE FOR THE PREPARATION OF A MEDICATION FOR THE PREVENTIVE THERAPY FOR PAIN | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 2002-12-05 | — | — | WO | claimed |
| WO-2002096411-A1 | USE OF AN ALKANOYL L-CARNITINE FOR THE PREPARATION OF A MEDICATION TO TREAT ANHEDONIA | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 2002-12-05 | — | — | WO | claimed |
| EP-0101185-B2 | Transfusion preparation for intravenous infusion | SHIMIZU SEIYAKU KK (JP) | 1994-04-06 | — | — | EP | claimed |
| EP-0219101-B1 | SILVER HALIDE PHOTOGRAPHIC MATERIAL | KONICA CORPORATION (JP) | 1992-12-30 | — | — | EP | claimed |
| EP-0483261-A1 | HIRUDIN PEPTIDE DERIVATIVES | BIOGEN, INC. (US) | 1992-05-06 | — | — | EP | claimed |
| WO-1991001328-A1 | HIRUDIN PEPTIDE DERIVATIVES | BIOGEN, INC. (US) | 1991-02-07 | — | — | WO | claimed |
| US-4935338-A | Silver halide photographic material containing aqueous latex having coated polymer particles | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1990-06-19 | — | — | US | claimed |
| WO-1990006128-A1 | METHODS AND COMPOSITIONS FOR INHIBITING PLATELET AGGREGATION | BIOGEN, INC. (US) | 1990-06-14 | — | — | WO | claimed |
| EP-0372670-A2 | Hirudin peptides for inhibiting platelet aggregation | BIOGEN, INC. (US) | 1990-06-13 | — | — | EP | claimed |
| EP-0005867-A1 | An alpha-amylase assay, a reagent composition and a reagent system therefor | COOPERBIOMEDICAL, INC. (US) | 1979-12-12 | — | — | EP | claimed |